Previous studies showed that social media platforms have improved public awareness of GLP-1 RAs as a first-line treatment for obesity, with demonstrated effectiveness in weight loss.[27] This could have led to the better awareness and comprehension related to these medications. The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.